Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer. Ronnlund C, Sifakis EG, Schagerholm C, Yang Q, et al. Breast Cancer Res 2024;26:24.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ronnlund C, Sifakis EG, Schagerholm C, Yang Q, et al. Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer. Breast Cancer Res 2024;26:24.
PMID: 38321542